Anticoagulation following tissue aortic valve replacement

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2006
INTERVENTION: Three groups: warfarin therapy for 90 days, aspirin therapy for 90 days, control group (no medication) CONDITION: Aortic valve disease ; Circulatory System ; Aortic valve disease PRIMARY OUTCOME: 1. Neurological events; 2. Stroke SECONDARY OUTCOME: Thrombus formation INCLUSION CRITERIA: Patients undergoing tissue aortic valve replacement
Epistemonikos ID: d38a3b07a50b231f13ef56a9b8a37f60101da601
First added on: Aug 21, 2024